Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pure CBG, the commercial brand of PureForm Global, is a biotechnology company focused on the production of high-purity, synthetic cannabinoids for the pharmaceutical and wellness industries. Utilizing a proprietary Cyclic Terpene Assembly (CTA) technology, the company manufactures bio-identical Cannabigerol (CBG) and Cannabidiol (CBD) that are entirely free from THC and plant-derived impurities. This synthetic approach allows for precise molecular control, ensuring consistent quality and scalability that traditional hemp extraction cannot match. Pure CBG's products are utilized in clinical research and commercial formulations targeting a wide range of conditions, including chronic pain, inflammation, and neurodegenerative disorders. The company operates as a key supplier and partner for life science firms seeking regulatory-compliant cannabinoid ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pure CBG.